From the Website of AFP
links: http://www.afp.mil.ph/index.php/8-afp-news/532-scholarship-for-soldiers-dependents-now-open
CAMP AGUINALDO, Quezon City -
Dependents of soldiers completing their bachelor's degree in Pharmacy
may now avail of full scholarship following a renewed partnership
between the Armed Forces of the Philippines (AFP) and Mercury Drug
Foundation Inc. (MDFI) this year.
Starting this school year, military
dependents taking up pharmacy may enjoy free tuition and miscellaneous
fees in accredited Colleges in the Philippines. Monthly allowances to
cover for food and transportation expenses will also be provided to
scholars. Jobs at Mercury Drug Corporation upon graduation will also be
offered.
The qualified applicants are dependents
of soldiers who are in the active service, killed-in-action,
incapacitated (combat or non-combat), or died in the line of duty. They
must be in the last two years of their studies in Pharmacy or willing to
transfer to schools that are members of the Philippine Association of
Colleges of Pharmacy.
The AFP extends its gratitude to the
MDFI, and all stakeholders for being partners in uplifting the morale
and welfare of soldiers. The AFP hopes that more organizations will
extend assistance to the AFP in helping soldiers and their families
secure a better future.
For further information on accredited
schools and other requirements on the AFP-MDFI scholarship program,
applicants may contact the following numbers:
Landline: 912-9606 or 911-6001 loc 6009/6010;
Mobile: 0917-507-6617, 0999-993-3376, 0932-843-5446.
Mobile: 0917-507-6617, 0999-993-3376, 0932-843-5446.
Application is until 28 February 2018.
AFP Websites
links:
OTHER HUMAN RIGHTS PROMOTIONS WEBSITES
Human Rights Advocacy Promotions | Human Rights
Human Rights Advocacy Promotions | Human Rights
PROTECTION AND PROMOTION OF HUMAN RIGHTS
-----------------------------------------------------------------------------------------------
------------------------------------------------------------
----------------------------
------------------------------------------------------------
----------------------------
0 comments:
Post a Comment